Posted by Michael Wonder on 05 Mar 2019
Evaluating Canadians’ values for drug coverage decision making
2 March 2019 - Decision makers are facing growing challenges in prioritising drugs for reimbursement because of soaring drug costs and increasing pressures on financial resources.
In addition to cost and effectiveness, payers are using other values to dictate which drugs are prioritised for funding, yet there are limited data on the Canadian public’s priorities.
Rizzardo et al. conducted an online survey of 2539 Canadians aged 19 years and older was performed in which 13 values used in drug funding prioritisation were ranked and then weighted using an analytic hierarchy process.
